These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38237848)

  • 1. CLSPN actives Wnt/β-catenin signaling to facilitate glycolysis and cell proliferation in oral squamous cell carcinoma.
    Hou Z; Wu C; Tang J; Liu S; Li L
    Exp Cell Res; 2024 Feb; 435(2):113935. PubMed ID: 38237848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunity-related long noncoding RNA WDFY3-AS2 inhibited cell proliferation and metastasis through Wnt/β-catenin signaling in oral squamous cell carcinoma.
    Lin X; Ding JM; Zheng XZ; Chen JG
    Arch Oral Biol; 2023 Mar; 147():105625. PubMed ID: 36657277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of lncRNA IGF2BP2-AS1 inhibits proliferation and migration of oral squamous cell carcinoma cells via the Wnt/β-catenin pathway.
    Tong S; Wang X; Guo X; Lu Z
    J Oral Pathol Med; 2022 Mar; 51(3):272-280. PubMed ID: 34637162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RELA promotes the progression of oral squamous cell carcinoma via TFAP2A-Wnt/β-catenin signaling.
    Yang K; Zhao J; Liu S; Man S
    Mol Carcinog; 2023 May; 62(5):641-651. PubMed ID: 36789977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA, TUG1 regulates the oral squamous cell carcinoma progression possibly via interacting with Wnt/β-catenin signaling.
    Liang S; Zhang S; Wang P; Yang C; Shang C; Yang J; Wang J
    Gene; 2017 Apr; 608():49-57. PubMed ID: 28119088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA AC007271.3 promotes cell proliferation, invasion, migration and inhibits cell apoptosis of OSCC via the Wnt/β-catenin signaling pathway.
    Shao TR; Zheng ZN; Chen YC; Wu QQ; Huang GZ; Li F; Zeng WS; Lv XZ
    Life Sci; 2019 Dec; 239():117087. PubMed ID: 31759044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baicalin exerts anti-tumor effects in oral squamous cell carcinoma by inhibiting the microRNA-106b-5p-Wnt/β-catenin pathway via upregulating disabled homolog 2.
    Wang X; Zhang Y; Zhang S; Duan L
    Arch Oral Biol; 2021 Oct; 130():105219. PubMed ID: 34364169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
    Li GH; Ma ZH; Wang X
    Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MFAP2 promotes the progression of oral squamous cell carcinoma by activating the Wnt/β-catenin signaling pathway through autophagy.
    Zhang H; Shen S; Feng C; Chen G; Wang X
    Acta Biochim Biophys Sin (Shanghai); 2023 Aug; 55(9):1445-1455. PubMed ID: 37592847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NCAPD2 promotes the malignant progression of oral squamous cell carcinoma via the Wnt/β-catenin pathway.
    Ma P; Yu H; Zhu M; Liu L; Cheng L; Han Z; Jin W
    Cell Cycle; 2024 Mar; 23(5):588-601. PubMed ID: 38743408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WNT3 promotes chemoresistance to 5-Fluorouracil in oral squamous cell carcinoma via activating the canonical β-catenin pathway.
    Zhang X; Sun K; Gan R; Yan Y; Zhang C; Zheng D; Lu Y
    BMC Cancer; 2024 May; 24(1):564. PubMed ID: 38711026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRAF4 enhances oral squamous cell carcinoma cell growth, invasion and migration by Wnt-β-catenin signaling pathway.
    Yang J; Wei D; Wang W; Shen B; Xu S; Cao Y
    Int J Clin Exp Pathol; 2015; 8(9):11837-46. PubMed ID: 26617938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-92a inhibits proliferation and promotes apoptosis of OSCC cells through Wnt/β-catenin signaling pathway.
    Zheng TL; Cen K
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4803-4809. PubMed ID: 32432743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Notum leads to potential pro-survival of OSCC through crosstalk between Shh and Wnt/β-catenin signaling via p-GSK3β.
    Yang P; Li C; Zhou Q; Zhang X; Kou Y; Feng Q; Wang H; Su R; Hasegawa T; Liu H; Li M
    Int J Biochem Cell Biol; 2022 Dec; 153():106316. PubMed ID: 36280040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NEDD4L inhibits glycolysis and proliferation of cancer cells in oral squamous cell carcinoma by inducing ENO1 ubiquitination and degradation.
    Zhang G; Zhao X; Liu W
    Cancer Biol Ther; 2022 Dec; 23(1):243-253. PubMed ID: 35316145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of PER2 Promotes Tumor Progression by Enhancing Glycolysis via the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway in Oral Squamous Cell Carcinoma.
    Long W; Gong X; Yang Y; Yang K
    J Oral Maxillofac Surg; 2020 Oct; 78(10):1780.e1-1780.e14. PubMed ID: 32615095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of Nav1.5 inhibits cell proliferation, migration and invasion via Wnt/β-catenin signaling pathway in oral squamous cell carcinoma.
    Xu X; Dai Y; Feng L; Zhang H; Hu Y; Xu L; Zhu X; Jiang Y
    Acta Biochim Biophys Sin (Shanghai); 2020 May; 52(5):527-535. PubMed ID: 32400862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STIP1 down-regulation inhibits glycolysis by suppressing PKM2 and LDHA and inactivating the Wnt/β-catenin pathway in cervical carcinoma cells.
    Li R; Li P; Wang J; Liu J
    Life Sci; 2020 Oct; 258():118190. PubMed ID: 32777299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TIMELESS promotes reprogramming of glucose metabolism in oral squamous cell carcinoma.
    Chen Y; Han Z; Zhang L; Gao C; Wei J; Yang X; Han Y; Li Y; Zhang C; Wei Y; Dong J; Xun W; Sun W; Zhang T; Zhang H; Chen J; Yuan P
    J Transl Med; 2024 Jan; 22(1):21. PubMed ID: 38178094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic restraint stress promotes the tumorigenic potential of oral squamous cell carcinoma cells by reprogramming fatty acid metabolism via CXCL3 mediated Wnt/β-catenin pathway.
    Lou F; Long H; Luo S; Liu Y; Pu J; Wang H; Ji P; Jin X
    Exp Neurol; 2023 Jan; 359():114268. PubMed ID: 36343679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.